Central Nervous System

Build from a solid knowledge base for new discoveries

Count on Quintiles' broad and deep CNS expertise to inform every stage of your program. Our team of experts and data-driven approach help you reduce costs, accelerate timelines and manage risk.

banner_pills

Quintiles helped develop or commercialize 100% of Top 50 best selling CNS products or compounds of 2013

CNS study challenges demand insightful planning

Recruitment difficulties, subjective outcome measures, treatment adherence issues—these hurdles can be anticipated and overcome. Careful planning is rewarded.

Navigate the challenges of your CNS studies

Quintiles can help you reduce costs, accelerate timelines and manage risk in your central nervous system programs. Our approach is to partner with you to plan and implement any CNS initiative, from Alzheimer’s trials to pain studies, applying our broad and deep CNS expertise at every stage of the process.

With a team of experts and a data-driven approach, complications can be avoided and obstacles can be eliminated all along the way:

  • Clinical development. Leverage our proficiency in protocol design, biomarker strategies and diagnostic imaging technologies to open new doors for CNS research.
  • Trial operations. Accelerate recruitment and streamline trials with our global medical and operational staff.
  • Outcomes reporting. Explore the nuances of subjective outcomes by drawing on the insight of our trained investigators. 
  • Commercial strategies. Speed market entry with the support of sales and marketing specialists who have neuroscience experience. 

Access a deep CNS knowledge base

Quintiles helped develop or commercialize 100% of the top 50 best-selling CNS products or compounds. Our centers of excellence include acute care and pain, autism, neurology and psychiatry. Our deep knowledge includes psychological and neurological disorders, including: ADHD, bipolar disorders, multiple sclerosis, sleep disorders, addiction disorders, depression, pain, stroke, Alzheimer’s disease, epilepsy, Parkinson’s disease, anxiety, migraine and schizophrenia.

The power of possibilities

Our success in central nervous system research can be seen in the success of our customers. By helping them anticipate and overcome obstacles, they’ve been able to successfully bring new therapies to market.

Quintiles Expert

Vice President, Therapeutic and Strategy Head, Global Central Nervous System

Recent thinking: EU Consortium to Streamline Alzheimer's Disease Research